(18)F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma.

Carlino, Matteo S; Saunders, Catherine A B; Haydu, Lauren E; Menzies, Alexander M; Martin Curtis, C; Lebowitz, Peter F; Kefford, Richard F; Long, Georgina V

Carlino, Matteo S; Saunders, Catherine A B; Haydu, Lauren E; Menzies, Alexander M; Martin Curtis, C; Lebowitz, Peter F; Kefford, Richard F; Long, Georgina V.

Affiliation

Carlino MS; Westmead Millennium Institute, The University of Sydney, Sydney, Australia. matteo.carlino@sydney.edu.au

Eur J Cancer ; 49(2): 395-402, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22981500

Subject(s)

Fluorodeoxyglucose F18; Imidazoles/administration & dosage; Melanoma/diagnostic imaging; Melanoma/drug therapy; Oximes/administration & dosage; Proto-Oncogene Proteins B-raf/genetics; Radiopharmaceuticals; Adult; Dose-Response Relationship, Drug; Female; Humans; Imidazoles/adverse effects; Male; Melanoma/genetics; Melanoma/pathology; Mutation; Oximes/adverse effects; Positron-Emission Tomography/methods; Prognosis; Protein Kinase Inhibitors/administration & dosage; Protein Kinase Inhibitors/adverse effects; Proto-Oncogene Proteins B-raf/antagonists & inhibitors; Survival Analysis; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oximes / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Proto-Oncogene Proteins B-raf / Imidazoles / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2013 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google